Pharmaceutical Supply – Doxycycline Hyclate Tablets

The contract entails the manufacture and supply of 2,000 bottles of Doxycycline Hyclate Tablets, identified by NSN 6505016421190 and NDC 24658-0312-10, under strict compliance with FDA current Good Manufacturing Practices and Defense Logistics Agency standards. The production must meet all regulatory and quality requirements to ensure the pharmaceuticals are safe, effective, and suitable for military and government use. The agreement is structured as a subcontract under the broader procurement framework of the Department of Defense, specifically managed by the Defense Logistics Agency, with the NAICS code 325412 indicating classification within pharmaceutical preparation manufacturing. Performance of the contract is tied to U.S. government specifications, with delivery expected to meet exacting timelines and quality controls established by DLA. The contract was posted on June 26, 2026, and is referenced under the procurement identifier SPE2DX25D8022 with delivery order SPE2D926F6862. No specific location is designated for performance or delivery, suggesting flexibility in manufacturing and logistics as long as final product compliance and distribution align with DLA directives. The subcontractor is responsible for full adherence to all regulatory, packaging, labeling, and documentation requirements necessary for federal pharmaceutical procurement.